BFEC
MEDP icon

Benjamin F. Edwards & Company’s Medpace MEDP Stock Holding History

Benjamin F. Edwards & Company’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$353K Buy
856
+75
+10% +$29.7K 0.01% 773
2024
Q1 		$316K Buy
781
+39
+5% +$13.7K 0.01% 772
2023
Q4 		$227K Buy
+742
New +$200K ﹤0.01% 844
2021
Q2 		– Sell
-2,018
Closed -$331K – 1735
2021
Q1 		$331K Buy
2,018
+52
+3% +$7.95K 0.02% 555
2020
Q4 		$274K Buy
1,966
+392
+25% +$49.4K 0.02% 557
2020
Q3 		$176K Buy
1,574
+596
+61% +$68.9K 0.01% 618
2020
Q2 		$91K Buy
978
+527
+117% +$44.8K 0.01% 764
2020
Q1 		$33K Sell
451
-89
-16% -$7.73K ﹤0.01% 938
2019
Q4 		$45K Hold
540
– – ﹤0.01% 996
2019
Q3 		$45K Hold
540
– – ﹤0.01% 957
2019
Q2 		$35K Hold
540
– – ﹤0.01% 1005
2019
Q1 		$32K Buy
540
+140
+35% +$8.36K ﹤0.01% 995
2018
Q4 		$21K Hold
400
– – ﹤0.01% 1078
2018
Q3 		$24K Buy
+400
New +$21.9K ﹤0.01% 1065

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

Benjamin F. Edwards & Company's MEDP Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Medpace (MEDP) stake by 9.6% in Q2 2024, buying an estimated $29.7K and bringing the position to 856 shares worth $353K. The position accounts for 0.01% of the portfolio, ranked #773.

Benjamin F. Edwards & Company first reported a position in MEDP in Q3 2018 and has held it in 14 quarters since. 623 funds tracked by Wall St. Rank hold MEDP as of Q2 2024.

  • Benjamin F. Edwards & Company held 856 shares of Medpace worth $353K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 75 Medpace shares in Q2 2024, an estimated $29.7K.
  • Medpace made up 0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #773 holding.
  • Benjamin F. Edwards & Company first reported a position in Medpace in Q3 2018 and has held it in 14 quarters since.
  • 623 funds tracked by Wall St. Rank held Medpace as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.